RGS11

RGS11 is an R7-family regulator of G-protein signaling that functions as a GTPase-accelerating protein (GAP) selective for Gi-family Gα subunits, particularly Gαo, and operates obligatorily as a heterodimer with Gβ5 (PMID:9789084, PMID:12531899). Selectivity is defined biochemically: the purified Gβ5/RGS11 dimer stimulates GTP hydrolysis on Gαo, Gαi1, Gαi2, and Gαi3 but not Gαq or Gα11, and exhibits the highest maximal GAP activity among R7 family members tested (PMID:12531899). The Gβ5 interaction is mediated by RGS11's GGL domain, which engages Gβ5 in a manner analogous to conventional Gβ/Gγ pairing through a conserved aromatic residue (PMID:9789084, PMID:10339615). In retinal ON-bipolar cells RGS11 assembles into a trimeric complex with the Gβ5 short isoform (Gβ5S) and the membrane anchor R9AP, is targeted to dendritic tips through direct association with the receptor mGluR6, and depends on both R9AP and mGluR6 for proteolytic stability (PMID:19625520, PMID:20100392). R9AP both colocalizes the complex with Gαo at the membrane and allosterically potentiates its GAP activity, an effect required for GTPase acceleration in the mGluR6–Gαo pathway (PMID:20007977). Functionally, RGS11 acts redundantly with RGS7 as the dominant GAP of this pathway, setting the magnitude and onset kinetics of the light response by deactivating Gαo upstream of TRPM1 channel gating (PMID:22547806). Beyond retinal signaling, RGS11 forms a complex with CaMKII and the transcription factor ATF3 in cardiomyocytes, where it counteracts oxidative stress, mitochondrial dysfunction, and apoptosis to limit doxorubicin-induced cardiac fibrosis (PMID:36228439).

1. 1998 High

   Established the core biochemical identity of RGS11 by showing it carries a GGL domain that recruits Gβ5 and that the resulting dimer is a selective GAP, defining the protein as an R7-family RGS rather than a free-standing RGS.

   Evidence Coexpression, co-immunoprecipitation, and GAP activity assay in cells

   PMID:9789084

   Open questions at the time

   • Selectivity among Gi-family subunits not yet quantified with purified components
   • Structural basis of GGL–Gβ5 binding not resolved
2. 1999 High

   Resolved how RGS11 binds Gβ5 at the residue level, showing the GGL domain mimics a conventional Gγ subunit and identifying a critical conserved aromatic residue, explaining the obligate heterodimer.

   Evidence GGL domain mutagenesis with Gβ binding assays in coexpression

   PMID:10339615

   Open questions at the time

   • Does not address GAP catalytic mechanism
   • No in vivo confirmation of binding interface
3. 2003 High

   Defined the G-protein substrate selectivity of the purified dimer, demonstrating activity restricted to Gi-family Gα and ranking RGS11 as the most efficacious R7 GAP, establishing the functional substrate repertoire.

   Evidence Purified Sf9-derived Gβ5/RGS11 in steady-state GTPase assays with receptor-coupled proteoliposomes

   PMID:12531899

   Open questions at the time

   • Steady-state assay does not isolate single-turnover catalytic rate
   • Cellular regulators of GAP activity not addressed
4. 2009 High

   Placed RGS11 in its native retinal context by defining the obligate trimeric complex with Gβ5S and R9AP and its mGluR6-directed dendritic targeting, linking the GAP to the ON-bipolar light response apparatus.

   Evidence Reciprocal co-IP, immunofluorescence, knockout mice, and electrophysiology

   PMID:19625520

   Open questions at the time

   • Determinants of postsynaptic targeting independent of R9AP not identified
   • Stoichiometry of the complex at dendritic tips not quantified
5. 2009 High

   Showed R9AP is not merely an anchor but allosterically potentiates RGS11×Gβ5 GAP activity toward Gαo and is required for GTPase acceleration in the mGluR6–Gαo pathway, defining the molecular role of the third subunit.

   Evidence Single-turnover GTPase assay, membrane reconstitution, Xenopus oocyte expression

   PMID:20007977

   Open questions at the time

   • Structural basis of allosteric potentiation unknown
   • Membrane geometry contribution versus direct allostery not fully separated
6. 2009 Medium

   Identified R7BP as a high-affinity binding partner of Gβ5-free RGS11 and quantified RGS11–Gαo and Gαo–R7BP affinities, extending the interaction network beyond the canonical dimer.

   Evidence Purified truncated recombinant RGS11 from E. coli with binding-affinity and GTPase assays

   PMID:19497306

   Open questions at the time

   • Single lab, single study
   • Physiological relevance of Gβ5-free RGS11–R7BP binding not tested in cells
7. 2010 Medium

   Confirmed in vivo that R9AP is required for proteolytic stability of the RGS11–Gβ5 complex and that the complex accelerates the initial light response, distinguishing RGS11 stability dependence from RGS7.

   Evidence Immunofluorescence, Western blot of R9AP-knockout retina, electroretinography

   PMID:20100392

   Open questions at the time

   • Single lab
   • Mechanism of differential RGS11 versus RGS7 stability not resolved
8. 2012 High

   Defined RGS11's pathway position via genetic epistasis, showing RGS7 and RGS11 together are the dominant GAPs setting magnitude and onset of the ON-bipolar light response upstream of TRPM1 gating through Gαo deactivation.

   Evidence RGS7/RGS11 double-knockout mice, electroretinography, single-cell electrophysiology

   PMID:22547806

   Open questions at the time

   • Individual contributions of RGS7 versus RGS11 not fully separated
   • Quantitative coupling between Gαo deactivation rate and TRPM1 gating not modeled
9. 2022 Medium

   Extended RGS11 function beyond retina, identifying a cardiomyocyte complex with CaMKII and ATF3 that suppresses oxidative stress and apoptosis to limit doxorubicin-induced cardiac fibrosis, a role apparently distinct from canonical GAP signaling.

   Evidence Reciprocal co-IP, cardiac-specific overexpression and shRNA knockdown in mice, oxidative stress and functional cardiac assays

   PMID:36228439

   Open questions at the time

   • Single lab
   • Whether GAP activity is required for the cardioprotective role not established
   • Direct molecular contacts within the RGS11–CaMKII–ATF3 complex not mapped

• How RGS11's canonical Gβ5-dependent GAP function relates mechanistically to its cardiomyocyte CaMKII/ATF3 role, and whether the two functions share structural determinants, remains unresolved.
• No structural model of RGS11 in any complex
• No demonstration that GAP-dead RGS11 retains or loses cardioprotection
• Tissue distribution of non-retinal RGS11 functions uncharacterized